NHS framework for Selexipag tablets procurement.
NHS England is establishing a national framework for Selexipag tablets, a medication used for pulmonary arterial hypertension. The framework aims to secure supply of this pharmaceutical product for NHS trusts and health boards across the United Kingdom. Suppliers planning to introduce the specified molecule or with inquiries about the upcoming procurement are invited to contact the MPSC New Market Developments Team. The notice is a pre-procurement engagement, signaling an upcoming tender for the supply of Selexipag tablets.